Keywords
Epidemiology
Melanoma
How to Cite
Abstract
Cutaneous melanoma (CM) is an uncommon but often aggressive form of skin cancer due to its significant morbidity and high mortality rates. Although it accounts for less than 5% of all skin cancers, the majority of skin cancer-related deaths are from melanoma. To describe the profile of cutaneous melanoma cases in individuals over 50 years of age in the state of Alagoas, Brazil, between the years 2018 to 2022. This is a cross-sectional study of a descriptive nature. Data from cases of malignant melanoma of the skin, collected at the Department of Informatics of the Unified Health System, in the Oncology Panel, covering the period from 2013 to 2019 were used. The variables were gender, age group, treatment modality and staging. For systematization and data analysis, Microsoft Office Excel software was used. In the analyzed period, 19,612 confirmed cases of malignant melanoma of the skin were registered in Brazil. When analyzing the hospitalizations within the study period, according to the diagnosis regions, it is seen that the South Region had the highest incidence with 7,954 cases. Malignant skin melanoma represents a large number of cases in the Oncology Panel, most worryingly in men between 60 and 69 years old. Thus, knowledge of the epidemiological profile of those affected by CM in Brazil can serve as a tool for planning and allocating resources in health planning, ensuring access and quality of care. Likewise, greater attention is needed in the prevention and reporting of new cases.
References
AHMED, B.; QADIR, M. I.; GHAFOOR, S. Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment. Critical Reviews in Eukaryotic Gene Expression, v. 30, n. 4, p. 291–297, 2020.
ARNOLD, M. et al. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatology, v. 158, n. 5, p. 495–503, 30 mar. 2022.
CHANDRA PAL, H. et al. Phytochemicals for the Management of Melanoma. Mini-Reviews in Medicinal Chemistry, v. 16, n. 12, p. 953–979, 27 jul. 2016.
CONFORTI, C.; ZALAUDEK, I. Epidemiology and Risk Factors of Melanoma: A Review. Dermatology Practical & Conceptual, p. 2021161S, 28 jul. 2021.
DAVIS, L. E.; SHALIN, S. C.; TACKETT, A. J. Current state of melanoma diagnosis and treatment. Cancer Biology & Therapy, v. 20, n. 11, p. 1366–1379, 1 ago. 2019.
DATASUS. BRASIL. Ministério da Saúde. Banco de Dados do Sistema Único de Saúde. Disponível em: https://datasus.saude.gov.br/. Acesso em: 10 de junho de 2023
DE MELO, A. C. et al. Melanoma signature in Brazil: epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years. Melanoma Research, v. 28, n. 6, p. 629–636, dez. 2018.
DZWIERZYNSKI, W. W. Melanoma Risk Factors and Prevention. Clinics in Plastic Surgery, v. 48, n. 4, p. 543–550, 1 out. 2021.
FERREIRA, F. R.; NASCIMENTO, L. F. C. Mortality due to cutaneous melanoma in south region of Brazil: a spatial approach. Anais Brasileiros De Dermatologia, v. 91, n. 4, p. 437–441, 2016.
GOLDEMBERG, D. C. et al. Epidemiological profile of mucosal melanoma in Brazil. Scientific Reports, v. 10, n. 1, 16 jan. 2020.
HEISTEIN, J. B.; ACHARYA, U. Cancer, Malignant Melanoma. Disponível em: <https://www.ncbi.nlm.nih.gov/books/NBK470409/>.
NOGUEIRA, A. P. B. et al. Correction to: Factors Related to Delayed Diagnosis of Cutaneous Melanoma in the Brazilian Public Health System. Journal of Cancer Education: The Official Journal of the American Association for Cancer Education, v. 37, n. 4, p. 1260, 1 ago. 2022.
OSTROWSKI, S. M.; FISHER, D. E. Biology of Melanoma. Hematology/Oncology Clinics of North America, v. 35, n. 1, p. 29–56, fev. 2021.
PORTO, A. C. et al. Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil. PLOS ONE, v. 15, n. 10, p. e0240864, 23 out. 2020.
RASTRELLI, M. et al. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo (Athens, Greece), v. 28, n. 6, p. 1005–1011, 1 nov. 2014.
SANTOS, C. A. DOS; SOUZA, D. L. B. Melanoma mortality in Brazil: trends and projections (1998-2032). Ciência & Saúde Coletiva, v. 24, n. 4, p. 1551–1561, abr. 2019.
SCHADENDORF, D. et al. Melanoma. The Lancet, v. 392, n. 10151, p. 971–984, set. 2018.
SHIMADA, G. D. P. et al. Time-to-treatment initiation for cutaneous melanoma reflects disparities in healthcare access in Brazil: a retrospective study. Public Health, v. 210, p. 1–7, set. 2022.
SITUM, M. et al. Melanoma--clinical, dermatoscopical, and histopathological morphological characteristics. Acta dermatovenerologica Croatica: ADC, v. 22, n. 1, p. 1–12, 2014.
SWETTER, S. M. et al. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021. Journal of the National Comprehensive Cancer Network, v. 19, n. 4, p. 364–376, abr. 2021.
YEH, I.; BASTIAN, B. C. Melanoma pathology: new approaches and classification*. British Journal of Dermatology, v. 185, n. 2, p. 282–293, 31 maio 2021
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Rodrigo Daniel Zanoni, Danillo Barreto da Silva, Maurílio de Aguiar Cordeiro, Camila Rodrigues Rosa, Lucas Campos Rodrigues, Renata de Oliveira Machado Amorim, Lohana Vidaurre Salvatierra, Jilielisson Oliveira de Souza